Non-intensive acute myeloid leukemia therapies for older patients

R Babakhanlou, F Ravandi-Kashani - Expert review of hematology, 2023 - Taylor & Francis
Introduction Acute myeloid leukemia (AML) is an aggressive disease predominantly
affecting the elderly population. The elderly population represents a challenging group to …
被引用次数：4 相关文章

Non-intensive acute myeloid leukemia therapies for older patients

R Babakhanlou… - Expert review of …, 2023 - mdanderson.elsevierpure.com
Introduction: Acute myeloid leukemia (AML) is an aggressive disease predominantly
affecting the elderly population. The elderly population represents a challenging group to …

Non-intensive acute myeloid leukemia therapies for older patients

R Babakhanlou… - Expert review of …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Acute myeloid leukemia (AML) is an aggressive disease predominantly
affecting the elderly population. The elderly population represents a challenging group to …

Non-intensive acute myeloid leukemia therapies for older patients.

R Babakhanlou, F Ravandi-Kashani - Expert Review of Hematology, 2023 - europepmc.org
Acute myeloid leukemia (AML) is an aggressive disease predominantly affecting the elderly
population. The elderly population represents a challenging group to treat and the prognosis …
[PDF] researchgate.net

[PDF][PDF] Non-intensive acute myeloid leukemia therapies for older patients

R Babakhanlou, F Ravandi-Kashani - 2023 - researchgate.net
Introduction: Acute myeloid leukemia (AML) is an aggressive disease predominantly
affecting the elderly population. The elderly population represents a challenging group to …
[PDF] researchgate.net

[PDF][PDF] Non-intensive acute myeloid leukemia therapies for older patients

R Babakhanlou, F Ravandi-Kashani - 2023 - researchgate.net
Introduction: Acute myeloid leukemia (AML) is an aggressive disease predominantly
affecting the elderly population. The elderly population represents a challenging group to …